Translational Development Acquisition (TDAC) Cash & Equivalents (2023 - 2025)

Translational Development Acquisition (TDAC) posted Cash & Equivalents of $29787.0 for Q4 2025, down 36.83% on a QoQ basis from $47150.0 in Q3 2025.

Translational Development Acquisition (TDAC) Cash & Equivalents (2023 - 2025) Analysis & Trends

Translational Development Acquisition's Cash & Equivalents history runs 2 years deep, the most recent figure standing at $29787.0 for Q4 2025.

Quarterly Cash & Equivalents changed N/A year-over-year to $29787.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29787.0 (changed N/A YoY) and the FY2025 annual result came in at $29787.0, changed N/A from the prior year.
Cash & Equivalents was $29787.0 for Q4 2025 at Translational Development Acquisition, down from $47150.0 in the prior quarter.
Across five years, Cash & Equivalents topped out at $47150.0 in Q3 2025 and bottomed at $2021.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. (Qtr)
1	EQV Ventures Acquisition	480.75 Mn	480.75 Mn	-	1.47 Mn
2	Agriculture & Natural Solutions Acquisition	393.29 Mn	393.29 Mn	-	1.00
3	Berto Acquisition	314.56 Mn	314.35 Mn	-	209,000.00
4	GP-Act III Acquisition	313.66 Mn	313.66 Mn	-	250,000.00
5	Centurion Acquisition	311.65 Mn	311.65 Mn	-	28,828.00
6	Republic Digital Acquisition	310.50 Mn	309.63 Mn	-	868,792.00
7	Siddhi Acquisition Corp (Cayman Islands)	288.97 Mn	288.97 Mn	-	456,983.00
8	K&F Growth Acquisition	283.42 Mn	283.42 Mn	-	577,446.00
9	Bold Eagle Acquisition	275.29 Mn	275.29 Mn	-	521,352.00
10	Translational Development Acquisition	186.90 Mn	186.90 Mn	-	-

Download Data